Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
A retrospective observational study to review the safety and efficacy of rFVIIa in persistent hemorrhage in post cardiac surgical patients. Methods: Patients who had bleeding of 3 ml/kg/h or more for 2 consecutive hours after cardiac surgery were arranged into two groups; control group, who received...
Main Authors: | Aly Makram Habib, Ahmed Yehia Mousa, Zohair Al-Halees |
---|---|
Format: | Article |
Language: | English |
Published: |
Saudi Heart Association
2016-10-01
|
Series: | Journal of the Saudi Heart Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1016731516300173 |
Similar Items
-
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
by: Rajpurkar M, et al.
Published: (2018-11-01) -
Recombinant Activated Factor VII Treatment of Life-Threatening Rectus Sheath Hematoma in a Patient Receiving Enoxaparin, Aspirin, and Clopidogrel: A Case Report
by: Isawaruk Poonsawas, et al.
Published: (2020-07-01) -
BUDGET IMPACT ANALYSIS OF INHIBITOR HAEMOPHILIA A THERAPY WITH BYPASSING AGENTS
by: Konstantin Tachkov, et al.
Published: (2019-04-01) -
Uso del factor VII activado recombinante en pacientes no hemofílicos en Cuba Use of the recombinant activated factor VII in non-hemophilic patients in Cuba
by: Olga Agramonte Llanes, et al.
Published: (2008-12-01) -
Low-dose recombinant factor VIIa for massive bleeding
by: A Mordasini, et al.
Published: (2011-07-01)